| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SHIRE PLC | 130,000 | 22,149,000 | 12.98% | ||
| 2 | NOVARTIS A G | 198,000 | 14,422,000 | 8.45% | ||
| 3 | CELGENE CORP | 122,000 | 14,122,000 | 8.28% | ||
| 4 | ALEXION PHARMACEUTIC | 100,000 | 12,235,000 | 7.17% | ||
| 5 | PFIZER INC | 318,051 | 10,330,000 | 6.06% | ||
| 6 | ASTRAZENECA PLC | 300,000 | 8,196,000 | 4.80% | ||
| 7 | HORIZON PHARMA PLC | 500,000 | 8,090,000 | 4.74% | ||
| 8 | AstraZeneca PLC | 250,000 | 6,830,000 | 4.00% | Call | |
| 9 | KITE PHARMA INCORPORATED | 150,000 | 6,726,000 | 3.94% | ||
| 10 | TESARO Inc | 50,000 | 6,724,000 | 3.94% | Put | |
| 11 | ALNYLAM PHARMACEUTICALS INC | 165,000 | 6,178,000 | 3.62% | ||
| 12 | MINERVA NEUROSCIENCES INC COM | 492,958 | 5,792,000 | 3.40% | ||
| 13 | NEUROCRINE BIOSCIE COM USD0.001 | 120,000 | 4,644,000 | 2.72% | ||
| 14 | ACCELERON PHARMA | 178,000 | 4,543,000 | 2.66% | ||
| 15 | INSMED INC COM PAR .01 | 322,044 | 4,261,000 | 2.50% | ||
| 16 | EIGER BIOPHARMACEUTICALS INC | 263,600 | 3,071,000 | 1.80% | ||
| 17 | ABEONA THERAPEUTICS INC | 568,573 | 2,758,000 | 1.62% | ||
| 18 | ADAMAS PHARMACEUTICALS INC | 151,670 | 2,563,000 | 1.50% | ||
| 19 | FIBROGEN INC COM | 116,000 | 2,482,000 | 1.45% | ||
| 20 | TREVENA INC | 398,849 | 2,345,000 | 1.37% | ||
| 21 | CARA THERAPEUTICS INC | 250,000 | 2,323,000 | 1.36% | ||
| 22 | NewLink Genetics Corp | 200,000 | 2,056,000 | 1.21% | Call | |
| 23 | Ascendis Pharma | 100,000 | 2,024,000 | 1.19% | ||
| 24 | ZOGENIX INC | 150,000 | 1,823,000 | 1.07% | ||
| 25 | CONCERT PHARMACEUTICALS INC COM | 167,866 | 1,727,000 | 1.01% | ||
| 26 | PARATEK PHARMACEUTICALS INC | 100,000 | 1,540,000 | 0.90% | ||
| 27 | SANGAMO BIOSCIENCES INCORPORATED | 503,000 | 1,534,000 | 0.90% | ||
| 28 | ADVAXIS INC COM NEW | 200,000 | 1,432,000 | 0.84% | ||
| 29 | Axovant Sciences Ltd | 100,000 | 1,242,000 | 0.73% | Call | |
| 30 | IMMUNE DESIGN CORP COM | 198,600 | 1,092,000 | 0.64% | ||
| 31 | Clearside Biomedical Inc | 120,763 | 1,080,000 | 0.63% | ||
| 32 | Redhill Biopharma Ltd | 95,000 | 994,000 | 0.58% | ||
| 33 | GLOBAL BLOOD THERAPEUTICS IN COM | 60,000 | 867,000 | 0.51% | ||
| 34 | Intec Pharma Ltd | 138,845 | 791,000 | 0.46% | ||
| 35 | VistaGen Therapeutics Inc | 138,132 | 515,000 | 0.30% | ||
| 36 | Amicus Therapeutics Inc | 100,000 | 497,000 | 0.29% | Call | |
| 37 | VERASTEM INC COM | 336,000 | 376,000 | 0.22% | ||
| 38 | Vascular Biogenics Ltd | 33,332 | 162,000 | 0.09% | ||
| 39 | Tracon Pharmaceuticals Inc | 12,714 | 62,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001646343-17-000002, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
